Kate Hanrott

机构：Endo Pharmaceuticals (United States) · ORCID：0000-0002-9629-8491

发表论文 13 篇 · 总被引 227 次 · h-index 6

代表论文

Investigation of selective JAK1 inhibitor GSK2586184 for the treatment of psoriasis in a randomized placebo-controlled phase IIa study (2016 · British Journal of Dermatology · 被引 87)
A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR) (2022 · European Respiratory Journal · 被引 43)
Adaptive study design to assess effect of TRPV4 inhibition in patients with chronic cough (2021 · ERJ Open Research · 被引 36)
A Randomized Trial of Otilimab in Severe COVID-19 Pneumonia (OSCAR) (2021 · medRxiv · 被引 27)
An open‐label, dose‐escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertension (2021 · Pulmonary Circulation · 被引 16)
Effects of Recombinant Human Angiotensin-Converting Enzyme 2 on Response to Acute Hypoxia and Exercise: A Randomised, Placebo-Controlled Study (2021 · Pulmonary Therapy · 被引 8)